GeneCellNano 2023 Helsinki, April 13-14 Marcus Reay2023-04-11T14:52:24+02:00April 11th, 2023| Read More
DelSiTech Awarded a Grant to Develop Controlled and Sustained Release Injectables for Prophylactic HIV Vaccine Aleksi Leino2023-03-15T11:34:26+02:00March 15th, 2023| Read More
DelSiTech Ltd Announces Appointment of Dr. Sari Häkkinen as Chief Development Officer Aleksi Leino2023-03-22T16:06:07+02:00March 1st, 2023| Read More
CRS Long-acting injectables conference 2023 February 8-9 Ossi Leppänen2022-12-05T19:18:09+02:00December 4th, 2022| Read More
CPHI 2022 Frankfurt, November 1-3 Ossi Leppänen2022-10-12T13:37:23+02:00October 12th, 2022| Read More
Partnering Opportunities in Drug Delivery 2022 Boston, October 24-25 Ossi Leppänen2022-10-12T13:30:40+02:00October 12th, 2022| Read More
DelSiTech Starts a Clinical Trial with Its Eye Drop Product Ossi Leppänen2022-09-14T15:40:45+02:00September 14th, 2022| Read More